Roche says a second trial of Actemra revives hopes for IL-6. What now?
Roche’s Actemra — and the IL-6 drug class by extension — may have a role in the fight against Covid-19 after all.
Data from a new Phase …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
